NorDiag enters distribution and collaboration agreement with Molzym
NorDiag has also entered into a collaboration agreement with Molzym, primarily with the purpose of integrating NorDiag’s magnetic bead based sample preparation chemistry and low throughput automation platform with Molzym’s molecular diagnostic products among others their SepsiTest™.
“We have chosen NorDiag due to their geographic presence, competence and position in the clinical diagnostic market”, says Molzym CEO Jan Detmers.
“Growing revenues by taking in complementary products is a key element in our strategy going forward and the agreements with Molzym will be an important contributor in increasing volumes. We also intend to offer an OEM agreement for NorDiag’s products to Molzym, which will open for cross-sales and further increase revenues” says NorDiag CEO Mårten Wigstøl.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.